ASX:HSO

Healthscope (HSO) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
38.30 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.86%
Price Target
N/A

About Healthscope

Healthscope Limited provides healthcare services in Australia and New Zealand. The company operates through Hospitals Australia and Pathology New Zealand segments. It operates 43 private hospitals, including 30 acute hospitals, 7 mental health hospitals, and 6 rehabilitation hospitals with approximately 5,000 inpatient beds. The company also provides human pathology services under the Labtests, Southern Community Laboratories, and Northland Pathology brands; and veterinary and analytical pathology services under the Gribbles brand. The company was formerly known as Healthscope Hospitals Holdings Pty. Ltd. and changed its name to Healthscope Limited in July 2014. Healthscope Limited was founded in 1985 and is headquartered in Melbourne, Australia.

HSO Stock News Headlines

Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
4 top growth shares I’d buy today
See More Headlines
Receive HSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthscope and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2019
Today
5/03/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
17,100
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Outstanding Shares
1,748,630,016
Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Gordon Scott Ballantyne (Age 54)
    MD, CEO & Director
  • Mr. Michael Sammells
    Chief Financial Officer
  • Mr. Mark Briscoe
    Gen. Mang. of Operations
  • Mr. David Shirer
    Gen. Mang. of Investor Relations
  • Ms. Ingrid A. Player (Age 46)
    Group Exec. of Legal, Governance & Sustainability, Gen. Counsel and Sec.

HSO Stock Analysis - Frequently Asked Questions

How were Healthscope's earnings last quarter?

Healthscope Ltd (ASX:HSO) announced its earnings results on Thursday, February, 14th. The company reported $0.04 earnings per share for the quarter.

Is Healthscope a good dividend stock?

Healthscope (ASX:HSO) pays an annual dividend of A$0.07 per share and currently has a dividend yield of 2.86%.
Read our dividend analysis for HSO.

What other stocks do shareholders of Healthscope own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthscope investors own include UBS ETRACS CMCI Energy Total Return ETN (UBN), Primary Health Care (PRY) and Fortescue (FMG).

This page (ASX:HSO) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners